Cimatron Reports Q3 Revenues

With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the company's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of the future performance and involve risks and uncertainties, many of which are beyond the company's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company's filings with the Securities and Exchanges Commission. The company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

                                 CIMATRON LIMITED
                        CONSOLIDATED STATEMENTS OF INCOME
               (US Dollars in thousands, except for per share data)


                            Three months ended          Nine months ended
                               September 30,              September 30,
                           2008           2007       2008            2007

    Total revenue          9,864         7,915      30,571          18,759

    Total cost of
    revenue                1,711         1,533       5,627           3,210

    Gross profit           8,153         6,382      24,944          15,549

    Research and
    development expenses,
    net                    1,683         1,037       5,273           3,144

    Selling, general and
    administrative
    expenses               6,451         4,895      19,797          11,560

    Operating income
    (loss)                    19           450       (126)             845

    Financial Income, net.    92           117         127             262

    Taxes on Income         (33)          (69)        (26)            (73)

    Other                     33          (12)          43            (76)

    Net income             $ 111         $ 486        $ 18           $ 958
    Net income per
    share - basic and
    diluted               $ 0.01        $ 0.06      $ 0.00          $ 0.12

    Weighted average
    number of shares
    outstanding

    Basic EPS (in
    thousands)             9,329         7,902       9,357           7,860

    Diluted EPS (in
    thousands)             9,385         7,919       9,362           7,900




                                 CIMATRON LIMITED
               RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
               (US Dollars in thousands, except for per share data)


                                         Three months ended
                                           September 30,
                                              2008                                                      2007
                                                  GAAP            Adj.      NON-GAAP        GAAP        Adj.      NON-GAAP

        Total  revenue  (1)      9,864            248          10,112        7,915          -              7,915

        Total  cost  of
        revenue  (2)                  1,711        (147)            1,564        1,533          -              1,533

        Gross  profit                8,153            395            8,548        6,382          -              6,382

        Research  and
        development
        expenses,  net              1,683                -            1,683        1,037          -              1,037

        Selling,  general
        and  administrative
        expenses(2)                  6,451        (100)            6,351        4,895      (37)            4,858
        Operating  income
        (loss)                                  19            495                514            450          37                487

        Financial  Income,
        net.                                      92                -                  92            117          -                  117

        Taxes  on  Income  (3)    (33)              40                    7          (69)          -                (69)

        Other                                    33                -                  33          (12)          -                (12)

        Net  income                    $  111        $  535            $  646        $  486    $  37              $  523
        Net  income  per
        share  -  basic  and
        diluted                        $  0.01                            $  0.07      $  0.06                        $  0.07

        Weighted  average
        number  of  shares
        outstanding

        Basic  EPS  (in
        thousands)                    9,329                              9,329        7,902                          7,902

        Diluted  EPS  (in
        thousands)                    9,385                              9,385        7,919                          7,919

        (1)  Non-GAAP  adjustment  related  to  Gibbs'  assumed  support  contracts
                that  will  not  be  recognized  on  a  GAAP  basis  in  fiscal  2008  or
                thereafter  due  to  business  combination  accounting  rules.
        (2)  Non-GAAP  adjustment  to  exclude  non-cash  amortization  of  acquired
                intangible  assets.
        (3)  Non-GAAP  adjustment  to  exclude  deferred  taxes  related  to  business
                combination  accounting  rules.



                                                                CIMATRON  LIMITED
                    RECONCILIATION  BETWEEN  GAAP  AND  NON-GAAP  INFORMATION  (Cont.)
                            (US  Dollars  in  thousands,  except  for  per  share  data)


                                                                              Nine  months  ended
                                                                                  September  30,
                                                                    2008                                                2007
                                                  GAAP        Adj.        NON-GAAP          GAAP      Adj.    NON-GAAP

        Total  revenue  (1)      30,571        743            31,314        18,759                18,759

        Total  cost  of
        revenue  (2)                    5,627    (441)              5,186          3,210                  3,210

        Gross  profit                24,944    1,184            26,128        15,549                15,549

        Research  and
        development
        expenses,  net                5,273                            5,273          3,144                  3,144

        Selling,  general
        and  administrative
        expenses  (2)                19,797    (300)            19,497        11,560      (57)  11,503
        Operating  income
        (loss)                              (126)    1,484              1,358              845        57          902

        Financial  Income,
        net.                                      127                                127              262                      262

        Taxes  on  Income  (3)      (26)        118                    92            (73)                    (73)

        Other                                      43                                  43            (76)                    (76)


        Net  income                        $  18    $  1,602          1,620              958      $  57    1,015

        Net  income  per
        share  -  basic  and
        diluted                          $  0.00                          $  0.17          $  0.12              $  0.13

        Weighted  average
        number  of  shares
        outstanding

        Basic  EPS  (in
        thousands)                      9,357                            9,357            7,860                7,860

        Diluted  EPS  (in
        thousands)                      9,362                            9,362            7,900                7,900

        (1)  Non-GAAP  adjustment  related  to  Gibbs'  assumed  support  contracts
                that  will  not  be  recognized  on  a  GAAP  basis  in  fiscal  2008  or
                thereafter  due  to  business  combination  accounting  rules.
        (2)  Non-GAAP  adjustment  to  exclude  non-cash  amortization  of  acquired
                intangible  assets.
        (3)  Non-GAAP  adjustment  to  exclude  deferred  taxes  related  to  business
                combination  accounting  rules.



                                                          CIMATRON  LIMITED
                                                CONSOLIDATED  BALANCE  SHEETS
                                                  (US  Dollars  in  thousands)

                                                                                        September  30,        December  31,
                                                                                                2008                          2007

                      ASSETS
        CURRENT  ASSETS:
            Total  cash,  cash  equivalents  and
            short-term  investments                                    $  6,623                    $  9,026
            Trade  receivables                                                  6,984                        7,308
            Other  current  assets                                            2,780                        1,467
                Total  current  assets                                      16,387                      17,801

                Deposits  with  insurance  companies
                and  severance  pay  fund                                    3,121                        2,703

        LONG-TERM  INVESTMENTS:
            Marketable  investments                                                -                        1,158

                Net  property  and  equipment                            1,427                        1,337

                Total  other  assets                                          14,156                        4,328

                    Total  assets                                              $  35,091                  $  27,327

                            LIABILITIES  AND  SHAREHOLDERS'  EQUITY
        CURRENT  LIABILITIES:
            Short-term  bank  credit                                        $  118                        $  791
            Trade  payables                                                        1,547                        2,258
            Accrued  expenses  and  other  liabilities        7,605                        7,889
            Deferred  revenues                                                  4,010                            742
                  Total  current  liabilities                          13,280                      11,680

        LONG-TERM  LIABILITIES:
            Accrued  severance  pay                                          4,399                        3,929
            Long-term  loan                                                            352                            403
            Deferred  tax  liability                                        1,820                            282
            Total  long-term  liabilities                              6,571                        4,614

            Minority  interest                                                        16                              63

            Total  shareholders'  equity                              15,224                      10,970
                  Total  liabilities  and
                  shareholders'  equity                                $  35,091                  $  27,327



                                                              CIMATRON  LIMITED
                                  STATEMENTS  OF  CHANGES  IN  SHAREHOLDERS'  EQUITY

                                                          Share        Additional      Accumulated            Retained
                                                        capital        paid-in                other                  earnings
                                                                              capital        comprehensive    (accumulated
                                                                                                      income  (loss)        deficit)



        Balance  at
        December  31,  2007                $  265          $  13,530            $  (34)                $  (2,632)

        Changes  during  the  nine
        months  ended  September
        30,  2008:

        Net  income                                                                                                                        18
        Issuance  of  shares                    39                4,248
        Exercise  of  share  options                                14

        Unrealized  gain  on  available
        for-sale  securities                                                                    88

        Vesting  of  employee  stock
        options                                                                                            92
        Investment  in  treasury  stock
        Foreign  currency
        translation  adjustment              -                        -                (92)                                -

        Total
        comprehensive  loss

        Balance  at
        September  30,  2008              $  304          $  17,792                $  54                $  (2,614)
                                                    (US  Dollars  in  thousands)


        (continued)

                                                                  CIMATRON  LIMITED
                                      STATEMENTS  OF  CHANGES  IN  SHAREHOLDERS'  EQUITY
                                                                                                                                    Total
                                                                Treasury          Comprehensive        shareholders'
                                                                  stock              income  (loss)              equity
        Balance  at  December
        31,  2007                                        $  (159)                                                  $  10,970
        Changes  during  the
        nine  months  ended
        September  30,  2008:
        Net  income                                                                            18                                18
        Issuance  of  shares                                                                                          4,287
        Exercise  of  share  options                                                                                  14
        Unrealized  gain  on
        available  for-sale  securities                                      88                                88
        Vesting  of  employee
        stock  options                                                                                                          92
        Investment  in  treasury  stock    (153)                    (153)                          (153)
        Foreign  currency
        translation  adjustment                        -                      (92)                            (92)
        Total  comprehensive  loss                                          (139)
        Balance  at  September
        30,  2008                                        $  (312)                                                  $  15,224

                                                                (US  Dollars  in  thousands)



                                                                CIMATRON  LIMITED
                                                        STATEMENTS  OF  CASH  FLOWS
                                                      (US  Dollars  in  thousands)

                                                                                                                Nine  months  ended
                                                                                                                  September  30,
                                                                                                              2008                            2007

        Cash  flows  from  operating  activities:
        Net  income                                                                                  $  18                          $  958

        Adjustments  to  reconcile  net  income
        to  net  cash  provided  by  operating  activities:
        Depreciation  and  amortization                                          1,105                              561
        Increase  (decrease)  in  accrued  severance  pay                470                          (183)
        Vesting  of  employee  stock  options                                        92                                88
        Equity  in  losses  (earnings)  of  affiliates                        88                                51
        Minority  interest  in  earnings  (losses)  of
        consolidated  subsidiaries                                                    (47)                                37
        Deferred  taxes,  net                                                                    46                                  -

        Changes  in  assets  and  liabilities:
        Decrease  (increase)  in  accounts  receivable
        and  prepaid  expenses                                                            2,626                              649
        Decrease  (increase)  in  inventory                                          24                                32
        Decrease  (increase)  in  deposits  with  insurance
        companies  and  severance  pay  fund                                    (418)                              (2)
        Increase  (decrease)  in  debts  to  related  parties            23                                25
        Increase  (decrease)  in  trade  payables,  accrued
        expenses  and  other  liabilities                                        (501)                              794
        Net  cash  provided  by  operating  activities                  3,526                          3,010

        Cash  flows  from  investing  activities:
        Proceeds  from  sale  of  property  and  equipment                    2                                  -
        Proceeds  from  sale  and  redemption  of  bonds                1,245                              250
        Purchase  of  property  and  equipment                                (359)                          (437)
        Additional  payment  for  acquisition  of
        subsidiary                                                                            (1,250)                                  -
        Acquisition  of  newly-consolidated  subsidiaries
        (Appendix  A)                                                                        (4,765)                              301
        Net  cash  provied  by  (used  in)  investing
        activities                                                                            (5,127)                              114

        Cash  flows  from  financing  activities:
        Short-term  bank  credit                                                        (674)                                  4
        Long-term  bank  credit                                                            (39)                                32
        Proceeds  from  issuance  of  shares  upon  exercise
        of  options                                                                                      14                                88
        Investment  in  treasury  stock                                            (153)                                  -
        Net  cash  provided  by  (used  in)  financing
        activities                                                                                (852)                              124

        Net  increase  (decrease)  in  cash  and  cash
        equivalents                                                                          (2,453)                          3,248
        Effect  of  exchange  rate  changes  on  cash                            50                                39
        Cash  and  cash  equivalents  at  beginning  of
        period                                                                                        9,026                          5,597

        Cash  and  cash  equivalents  at  end  of  period            $  6,623                      $  8,884



                                                                CIMATRON  LIMITED
                                                        STATEMENTS  OF  CASH  FLOWS
                                                      (US  Dollars  in  thousands)

                                                                                                    Nine  months  ended
                                                                                                        September  30,
                                                                                                2008                      2007

        Appendix  A  -  Acquisition  of  subsidiary,
        net  of  cash  acquired
                Working  capital  -  excluding  cash              (714)
                Goodwill                                                              3,647
                Other  intangible  assets                                5,432
                Property  and  equipment                                      158
                Tax  Asset                                                                529
                                                                                              9,052

                Issuance  of  shares                                      (4,287)

                                                                                          $  4,765
        Appendix  B  -  Non-cash  transactions
                Purchase  of  property  on  credit                    $  43                      $  35




        Contact:

        Ilan  Erez,  Chief  Financial  Officer
        Cimatron  Ltd.
        Tel.:  +972-3-531-2121
        E-mail:  yael@commitment-IR.com

        Yael  Nevat,
        Commitment-IR.com
        Tel:  +972-9-714  8866,  +972-50-762-6215
        E-mail:  ilane@cimatron.com

 


« Previous Page 1 | 2             



Review Article Be the first to review this article

Featured Video
Editorial
Jeff RoweJeff's MCAD Blogging
by Jeff Rowe
Siemens Goes ECAD With Mentor Graphics Acquisition
Jobs
Mechanical Engineer for IDEX Corporation at West Jordan,, UT
Business Partner Manager for Cityworks - Azteca Systems, LLC at Sandy, UT
Senior Structural Engineer for Design Everest at San Francisco, CA
GIS Analyst II for Air Worldwide at Boston, MA
Upcoming Events
Design & Manufacturing, Feb 7 - 9, 2017 Anaheim Convention Center, Anaheim, CA at Anaheim Convention Center Anaheim CA - Feb 7 - 9, 2017
Innorobo 2017 at Docks de Paris Paris France - May 16 - 18, 2017
Display Week 2017 at Los Angeles Convention Center 1201 S Figueroa St Los Angeles CA - May 21 - 26, 2017
SolidCAM: Program your CNCs directly inside your existing CAD system.



Internet Business Systems © 2016 Internet Business Systems, Inc.
595 Millich Dr., Suite 216, Campbell, CA 95008
+1 (408)-337-6870 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering EDACafe - Electronic Design Automation GISCafe - Geographical Information Services TechJobsCafe - Technical Jobs and Resumes ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy Policy Advertise